9rxl: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
Line 1: Line 1:
'''Unreleased structure'''


The entry 9rxl is ON HOLD  until Paper Publication
==SARS-CoV-2 nucleocapsid C-terminal domain in complex with BCY00018176==
<StructureSection load='9rxl' size='340' side='right'caption='[[9rxl]], [[Resolution|resolution]] 1.46&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[9rxl]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2 Severe acute respiratory syndrome coronavirus 2]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9RXL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9RXL FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.46&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=LFI:1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-yl]-3-bromanyl-propan-1-one'>LFI</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9rxl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9rxl OCA], [https://pdbe.org/9rxl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9rxl RCSB], [https://www.ebi.ac.uk/pdbsum/9rxl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9rxl ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/NCAP_SARS2 NCAP_SARS2] Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication.
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Constrained bicyclic peptides (Bicycle molecules) with high affinity for biological targets have emerged as potentially powerful therapeutic agents, particularly for the in vivo targeting of cancer receptors. However, their antibody-mimetic properties have yet to be explored for use in diagnostic immunoassays. These synthetically derived compounds serve as biorecognition scaffolds that allow for facile site-selective modification and large-scale production. A phage display screen against various constructs of the SARS-CoV-2 nucleocapsid (N) protein identified several Bicycle molecules with binding affinities ranging from the micromolar to the low nanomolar range. These Bicycle molecules were validated in the development of enzyme- and nanozyme-linked immunosorbent assays, as well as enzymatic and colorimetric nanoparticle-based lateral flow immunoassays (LFIA) for the detection of ultralow concentrations of the SARS-CoV-2 N protein. We envision that these moieties enable robust, cost-effective, and large-scale development of ultrasensitive biosensors for a diverse range of biomarkers by leveraging their high binding affinity, minimalistic scaffold, and synthetic accessibility.


Authors: Brear, P., Lulla, A., Dods, R., Bezerra, G.A., Hyvonen, M.
Utilizing Constrained Bicyclic Peptides for In Vitro Diagnostics.,Shamsabadi A, Creamer A, Sadler CJ, Abdelwahed A, Gaynor KU, Demydchuk Y, Ivanova-Berndt G, Van Rietschoten K, Beswick P, Chen L, Arruda Bezerra G, Lulla A, Brear P, Hyvonen M, Skynner MJ, Stevens MM ACS Nano. 2026 Feb 24;20(7):5928-5939. doi: 10.1021/acsnano.5c19041. Epub 2026 , Feb 13. PMID:41685809<ref>PMID:41685809</ref>


Description: SARS-CoV-2 nucleocapsid C-terminal domain in complex with BCY00018176
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Hyvonen, M]]
<div class="pdbe-citations 9rxl" style="background-color:#fffaf0;"></div>
[[Category: Lulla, A]]
== References ==
[[Category: Dods, R]]
<references/>
[[Category: Brear, P]]
__TOC__
[[Category: Bezerra, G.A]]
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Severe acute respiratory syndrome coronavirus 2]]
[[Category: Bezerra GA]]
[[Category: Brear P]]
[[Category: Dods R]]
[[Category: Hyvonen M]]
[[Category: Lulla A]]

Latest revision as of 07:57, 4 March 2026

SARS-CoV-2 nucleocapsid C-terminal domain in complex with BCY00018176

9rxl, resolution 1.46Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA